Literature DB >> 7835912

Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide.

J Kulics1, A Circolo, R C Strunk, H R Colten.   

Abstract

Synthesis and secretion of the class III major histocompatibility complex (MHC) gene product, C4, were detected in human skin fibroblasts by metabolic labelling, immunoprecipitation and SDS-PAGE analysis. Pro-C4 (approximately 185,000 MW) was present in intracellular lysates, and the mature protein was present in extracellular media, with three bands of approximately 93,000, 75,000 and 33,000 MW, corresponding to the alpha, beta and gamma chains, respectively. C4 expression was increased in a dose-dependent manner by interferon-gamma (IFN-gamma), but was unaffected by interleukin-1 beta (IL-1 beta), IL-6 and tumor necrosis factor-alpha (TNF-alpha) alone, each of which augmented the expression of factor B, C3 and other complement proteins synthesized in fibroblasts. Simultaneous incubation of fibroblasts with IFN-gamma and TNF resulted in a synergistic increase in C4 synthesis. RNA blot analyses indicated that regulation of C4 synthesis by IFN-gamma and the combination of IFN-gamma and TNF was mediated primarily at a pretranslational level. Lipopolysaccharide (LPS) had no effect on C4 or HLA-DR synthesis in fibroblasts, either constitutive or IFN-gamma-regulated. These results are in contrast to the effects of LPS in monocytes, where LPS decreased constitutive synthesis and counter-regulated the IFN-gamma-enhanced expression of both C4 and HLA-DR. C2 expression in fibroblasts was also increased primarily by IFN-gamma. However, C2 synthesis was increased by LPS, 1L-1 and TNF, although to a lesser extent than the increase in synthesis of factor B stimulated by these mediators. These results show that up-regulation by IFN-gamma is a common feature of C2 and C4 expression in human cells that constitutively synthesize these proteins. In contrast, regulation of MHC class III and class II genes by LPS, TNF, IL-1, and IL-6 is cell- and gene-specific.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835912      PMCID: PMC1414926     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  41 in total

1.  Amino-terminal amino acid sequence of human leukocyte interferon.

Authors:  W P Levy; J Shively; M Rubinstein; U Del Valle; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

2.  Synovial fibroblast-like cells synthesize seven proteins of the complement system.

Authors:  Y Katz; R C Strunk
Journal:  Arthritis Rheum       Date:  1988-11

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Precursor complement protein (pro-C4) is converted in vitro to native C4 by plasmin.

Authors:  G Goldberger; H R Colten
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

Review 5.  The proteolytic activation systems of complement.

Authors:  K B Reid; R R Porter
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

6.  Use of a cDNA clone for the fourth component of human complement (C4) for analysis of a genetic deficiency of C4 in guinea pig.

Authors:  A S Whitehead; G Goldberger; D E Woods; A F Markham; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

7.  Complement biosynthesis by the human hepatoma-derived cell line HepG2.

Authors:  K M Morris; D P Aden; B B Knowles; H R Colten
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

8.  Regulation of monocyte/macrophage C2 production and HLA-DR expression by IL-4 (BSF-1) and IFN-gamma.

Authors:  B H Littman; F F Dastvan; P L Carlson; K M Sanders
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

9.  Identification and structural characterization of two incompletely processed forms of the fourth component of human complement.

Authors:  A C Chan; J P Atkinson
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  IL-1 and tumor necrosis factor. Similarities and differences in stimulation of expression of alternative pathway of complement and IFN-beta 2/IL-6 genes in human fibroblasts.

Authors:  Y Katz; R C Strunk
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

View more
  4 in total

1.  Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells.

Authors:  K Kitamura; A Andoh; T Inoue; Y Amakata; K Hodohara; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Production of the third and fourth component of complement (C3, C4) by smooth muscle cells.

Authors:  Y Ueda; K Nagasawa; H Tsukamoto; T Horiuchi; H Nishizaka; K Ikeda; Y Niho
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

3.  Molecular heterogeneity in deficiency of complement protein C2 type I.

Authors:  X Wang; A Circolo; M L Lokki; P G Shackelford; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome.

Authors:  Bristol Sorensen; James F Jones; Suzanne D Vernon; Mangalathu S Rajeevan
Journal:  Mol Med       Date:  2008-11-10       Impact factor: 6.354

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.